Cargando…
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
BACKGROUND: Although ALYREF has been demonstrated to have a role in a number of malignancies, its role in hepatocellular carcinoma (HCC) has received little attention. Our objective was to research at the prognostic value, biological role and relevance of ALYREF to the immune system in HCC. METHODS:...
Autores principales: | Wang, Zhen-Zhen, Meng, Tao, Yang, Ming-Ya, Wang, Wei, Zhang, Yan, Liu, Yu, Han, An-Qi, Wu, Jin, Wang, Hui-xiao, Qian, Bo, Zhu, Li-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079359/ https://www.ncbi.nlm.nih.gov/pubmed/35523010 http://dx.doi.org/10.1016/j.tranon.2022.101441 |
Ejemplares similares
-
ALYREF Drives Cancer Cell Proliferation Through an ALYREF-MYC Positive Feedback Loop in Glioblastoma
por: Wang, Jianjun, et al.
Publicado: (2021) -
ALYREF mediates RNA m(5)C modification to promote hepatocellular carcinoma progression
por: Xue, Chen, et al.
Publicado: (2023) -
Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration
por: Nong, Ju‐sen, et al.
Publicado: (2023) -
A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates
por: He, Jian, et al.
Publicado: (2022) -
LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
por: Li, Lan, et al.
Publicado: (2022)